PASITHEA THERAPEUTICS CORP. Income (Loss) from Continuing Operations, Per Basic Share
PASITHEA THERAPEUTICS CORP. (KTTA) reported Income (Loss) from Continuing Operations, Per Basic Share of -$12.69 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$2.87.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for the quarter ending 2024-06-30 was -$3.71.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for the quarter ending 2024-03-31 was -$3.70.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for the quarter ending 2023-09-30 was -$2.87.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for fiscal 2024 was -$12.69.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for fiscal 2023 was -$12.64.
- PASITHEA THERAPEUTICS CORP. income (loss) from continuing operations, per basic share for fiscal 2022 was -$9.29.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$12.69 10-K · filed 2025-03-24 | ||||||
| 2024-09-30 | -$2.87 10-Q · filed 2024-11-13 | -$10.28 10-Q · filed 2024-11-13 | |||||
| 2024-06-30 | -$3.71 10-Q · filed 2024-08-13 | -$7.41 10-Q · filed 2024-08-13 | |||||
| 2024-03-31 | -$3.70 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | -$12.64 10-K · filed 2025-03-24 | ||||||
| 2023-09-30 | -$2.87 10-Q · filed 2024-11-13 | -$0.14 10-Q · filed 2023-11-13 | -$8.13 10-Q · filed 2024-11-13 | -$0.41 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | -$2.75 10-Q · filed 2024-08-13 | -$0.14 10-Q · filed 2023-08-11 | -$5.26 10-Q · filed 2024-08-13 | -$0.26 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | -$2.60 10-Q · filed 2024-05-14 | -$0.13 10-Q · filed 2023-05-12 | |||||
| 2022-12-31 | -$9.29 10-K · filed 2024-03-29 | ||||||
| 2022-09-30 | -$0.16 10-Q · filed 2023-11-13 | -$0.31 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$0.09 10-Q · filed 2023-08-11 | -$0.15 10-Q · filed 2023-08-11 | |||||
| 2022-03-31 | -$0.06 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |